Publications by authors named "Manojkumar Bupathi"

Claim this Profile
A
A plain language summary of the TROPHY-U-01 study (Cohort 2): use of sacituzumab govitecan after immunotherapy in people with metastatic urothelial cancer who cannot take cisplatin-based chemotherapy.
Petros Grivas, Scott T Tagawa, Rohit K Jain, Manojkumar Bupathi, Arjun Balar

Future Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Renal Cell Carcinoma Post-Immune-Oncology and Vascular Endothelial Growth Factor Receptor Targeted Therapies.
Neil J Shah, Sneha Sura, Reshma Shinde, Junxin Shi, Manojkumar Bupathi

Cancers (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Clinical Outcomes with First-Line Systemic Treatment and Avelumab Maintenance in US Patients with Locally Advanced or Metastatic Urothelial Carcinoma: The SPEAR Bladder-II Study.
Sneha Sura, Manojkumar Bupathi, Valerie Morris, Paul Conkling, Karen Todoroff

Curr Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing patients with metastatic hormone-sensitive prostate cancer: a shared-care approach to combination therapy.
Anthony P Lam, David J Cahn, Manojkumar Bupathi

Clin Adv Hematol Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A shared-care approach to the management of patients with mHSPC: the oncology perspective.
Manojkumar Bupathi

Clin Adv Hematol Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of the shared-care approach when triplet therapy is selected in mHSPC: Q&A.
Anthony P Lam, David J Cahn, Manojkumar Bupathi

Clin Adv Hematol Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A plain language summary of the TROPHY-U-01 study: sacituzumab govitecan use in people with locally advanced or metastatic urothelial cancer.
Yohann Loriot, Arash Rezazadeh Kalebasty, Aude Fléchon, Rohit K Jain, Sumati Gupta, Manojkumar Bupathi

Future Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TROPHY-U-01 Cohort 2: A Phase II Study of Sacituzumab Govitecan in Cisplatin-Ineligible Patients With Metastatic Urothelial Cancer Progressing After Previous Checkpoint Inhibitor Therapy.
Daniel P Petrylak, Scott T Tagawa, Rohit K Jain, Manojkumar Bupathi, Arjun Balar

J Clin Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Meaningfulness of an Algorithm-Based Service for Analyzing Treatment Response in Patients with Metastatic Cancer Using FDG PET/CT.
Manojkumar Bupathi, Benjamin Garmezy, Michael Lattanzi, Minnie Kieler, Nevein Ibrahim

J Clin Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma.
Pavlos Msaouel, Randy F Sweis, Manojkumar Bupathi, Elisabeth Heath, Oscar B Goodman

Eur Urol Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sacituzumab Govitecan Demonstrates Efficacy across Tumor Trop-2 Expression Levels in Patients with Advanced Urothelial Cancer.
Yohann Loriot, Arjun V Balar, Daniel P Petrylak, Arash R Kalebasty, Petros Grivas, Manojkumar Bupathi

Clin Cancer Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab.
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Manojkumar Bupathi

J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3.
Petros Grivas, Damien Pouessel, Chandler H Park, Philippe Barthelemy, Manojkumar Bupathi

J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors.
Scott T Tagawa, Arjun V Balar, Daniel P Petrylak, Arash Rezazadeh Kalebasty, Yohann Loriot, Manojkumar Bupathi

J Clin Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Degree of Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma.
Kate Lynn J Bill, Nathan D Seligson, John L Hays, Achal Awasthi, Bryce Demoret, Manojkumar Bupathi

Oncologist· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidisciplinary sarcoma care.
Raphael E Pollock, Jason E Payne, Alan D Rogers, Stephen M Smith, O Hans Iwenofu, Manojkumar Bupathi

Curr Probl Surg· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biweekly cisplatin and gemcitabine in patients with advanced biliary tract cancer.
Daniel H Ahn, Josh Reardon, Chul W Ahn, Manojkumar Bupathi, Sameh Mikhail

Int J Cancer· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temozolomide post pazopanib treatment failure in patients with advanced sarcoma: A case series.
Manojkumar Bupathi, John L Hays, James L Chen

PLoS One· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic options for intrahepatic cholangiocarcinoma.
Manojkumar Bupathi, Daniel H Ahn, Tanios Bekaii-Saab

Hepatobiliary Surg Nutr· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experience.
Manojkumar Bupathi, Joud Hajjar, Stacie Bean, Siqing Fu, David Hong

Invest New Drugs· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others.
Manojkumar Bupathi, Christina Wu

J Gastrointest Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spotlight on bevacizumab in metastatic colorectal cancer: patient selection and perspectives.
Manojkumar Bupathi, Daniel H Ahn, Tanios Bekaii-Saab

Gastrointest Cancer· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular carcinoma: Where there is unmet need.
Manojkumar Bupathi, Ahmed Kaseb, Funda Meric-Bernstam, Aung Naing

Mol Oncol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical next-generation sequencing reveals aggressive cancer biology in adolescent and young adult patients.
Vivek Subbiah, Manojkumar Bupathi, Shumei Kato, Andrew Livingston, John Slopis

Oncoscience· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives.
Manojkumar Bupathi, Ahmed Kaseb, Filip Janku

Onco Targets Ther· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis